Certified by Founder
Lodge
DANNCE.ai
start up
United States
- Cambridge, Massachusetts
- 22/11/2024
- Pre-Seed
- $2,600,000
DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis​. Our platform takes patient video as input and uses our proprietary 3-D pose tracking and behavioral analysis algorithms to quantify behavior. DANNCE will help clinicians see the unseeable and drug developers generate real world evidence by using movement data and computer vision.
- Industry Biotechnology Research
- Website https://www.dannce.ai/
- LinkedIn https://www.linkedin.com/company/dannce-ai/
Related People
Rob BaldoniFounder
United States -
Boston, Massachusetts
Currently building a digital health tool to improve the standard of care for neurology as the CEO of dannce.ai
Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)